C4 Therapeutics, Inc. (CCCC)
3.49
-0.02
(-0.57%)
USD |
NASDAQ |
Sep 14, 10:51
C4 Therapeutics Price : 3.49 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 3.475 | 3.525 | 3.355 | 3.51 | 1.482M |
| Sep 10, 2026 | 3.40 | 3.41 | 3.31 | 3.40 | 1.168M |
| Sep 09, 2026 | 3.54 | 3.54 | 3.42 | 3.44 | 1.442M |
| Sep 08, 2026 | 3.72 | 3.735 | 3.55 | 3.55 | 2.175M |
| Sep 04, 2026 | 3.72 | 3.845 | 3.660 | 3.76 | 2.363M |
| Sep 03, 2026 | 3.83 | 3.85 | 3.70 | 3.74 | 2.228M |
| Sep 02, 2026 | 3.87 | 4.07 | 3.73 | 3.79 | 1.835M |
| Sep 01, 2026 | 3.68 | 3.935 | 3.660 | 3.87 | 2.364M |
| Aug 31, 2026 | 3.83 | 3.86 | 3.695 | 3.71 | 1.858M |
| Aug 28, 2026 | 4.07 | 4.10 | 3.83 | 3.85 | 1.829M |
| Aug 27, 2026 | 4.25 | 4.30 | 4.09 | 4.10 | 1.989M |
| Aug 26, 2026 | 4.17 | 4.24 | 4.03 | 4.24 | 1.862M |
| Aug 25, 2026 | 4.11 | 4.235 | 4.085 | 4.20 | 4.286M |
| Aug 24, 2026 | 3.97 | 4.14 | 3.81 | 4.10 | 1.753M |
| Aug 21, 2026 | 4.07 | 4.10 | 3.935 | 4.00 | 1.162M |
| Aug 20, 2026 | 4.14 | 4.15 | 3.832 | 4.03 | 2.273M |
| Aug 19, 2026 | 4.25 | 4.375 | 4.13 | 4.21 | 2.849M |
| Aug 18, 2026 | 4.21 | 4.30 | 4.105 | 4.18 | 2.879M |
| Aug 17, 2026 | 4.315 | 4.315 | 4.108 | 4.265 | 2.087M |
| Aug 14, 2026 | 4.07 | 4.315 | 3.895 | 4.24 | 3.399M |
| Aug 13, 2026 | 3.93 | 4.23 | 3.86 | 4.08 | 3.726M |
| Aug 12, 2026 | 3.95 | 3.995 | 3.825 | 3.90 | 1.957M |
| Aug 11, 2026 | 3.84 | 4.00 | 3.64 | 3.87 | 3.085M |
| Aug 10, 2026 | 3.75 | 3.75 | 3.60 | 3.62 | 1.964M |
| Aug 07, 2026 | 3.69 | 3.750 | 3.65 | 3.73 | 1.504M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Beam Therapeutics, Inc. | 24.37 |
| Rallybio Corp. | 17.02 |
| Q32 Bio, Inc. | 10.93 |
| Arrowhead Pharmaceuticals, Inc. | 81.44 |
| Oncolytics Biotech, Inc. | 0.7948 |
Price Related Metrics
| PS Ratio | 11.11 |
| Price to Book Value | 1.735 |
| Earnings Yield | -28.62% |
| Market Cap | 428.94M |